Omadacycline oral/injection and Recombinate
Determining the interaction of Omadacycline oral/injection and Recombinate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: omadacycline
Brand name: Nuzyra
Synonyms: Omadacycline (oral/injection), Omadacycline
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Recombinate (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Omadacycline oral/injection-Recombinate recombinant
- Omadacycline oral/injection-Recombivax
- Omadacycline oral/injection-Recombivax HB
- Omadacycline oral/injection-Recombivax HB Adult
- Omadacycline oral/injection-Recombivax HB Dialysis Formulation
- Omadacycline oral/injection-Recombivax HB Pediatric/Adolescent
- Recombinate-Omadacycline Tablets
- Recombinate-Omadacycline Tosylate
- Recombinate-Omalizumab
- Recombinate-Omalizumab Subcutaneous
- Recombinate-Ombitasvir, Paritaprevir, and Ritonavir
- Recombinate-Ombitasvir, paritaprevir, ritonavir and dasabuvir